Zhitong Finance App News, on March 12, Yuanda Pharmaceutical (00512.HK) announced its 2024 results. According to the announcement, the company achieved annual revenue of about HK$11.64 billion, an increase of about 12.8% year on year before exchange rate impact; net profit to mother was about HK$2.47 billion, up about 34.0% year on year after excluding exchange rate impact. With both revenue and profit, the company plans to distribute a total of approximately HK$910 million in dividends.

Zhitongcaijing · 03/12 15:09
Zhitong Finance App News, on March 12, Yuanda Pharmaceutical (00512.HK) announced its 2024 results. According to the announcement, the company achieved annual revenue of about HK$11.64 billion, an increase of about 12.8% year on year before exchange rate impact; net profit to mother was about HK$2.47 billion, up about 34.0% year on year after excluding exchange rate impact. With both revenue and profit, the company plans to distribute a total of approximately HK$910 million in dividends.